
PROVIDERS
NanoBone is a bone graft substitute consisting of nanocrystals of hydroxyapatite (HA) bioidentical to human bone, dispersed in an amorphous silica gel matrix (ASG).
®
NanoBone Technology
®
HA
-
Bioidentical to human bone
-
Forms a composite with ASG
-
NanoBone HA has 40x surface area of other HA-based bone grafts
ASG
-
Initiates Clotting Factor XII
-
Triggers angiogenesis and new bone formation
-
Rapidly replaced by an autologous organic matrix
Autologous organic matrix initiates cell-mediated bone formation and resorption

"I have complete confidence in arthrodesis achieved in a timely fashion with NanoBone with no threat of overgrowth or reactive airway marrow soft tissue associated with the biologics.”
Michael Schneier, MD,
Neurosurgical Consulting,
Las Vegas, NV
FEATURED CASE STUDIES
Scoliosis Fusion - Hoernschemeyer
Adolescent Idiopathic Scoliosis treated with posterior fusion and NanoBone
Post Cervical Fusion - Udani
Posterolateral use of nanocrystalline hydroxyapatite in prior multilevel ACDF patient
FEATURED CLINICAL ABSTRACT SUMMARIES
Rosenthal, H. Evaluating a Nanocrystalline Hydroxyapatite Bone Graft Substitute for the Treatment of Benign Bone Tumors. The Internet Journal of Orthopedic Surgery. 2022 Volume 30 Number 1, 1-5.
Wang, W., et al.,
Bone grafts and biomaterials substitutes for bone defect repair: A review.
Bioactive Materials.
2017; 2(4),
224-247.
Abedi, A. et al., Examination of the Role of Cells in Commercially Available Cellular Allografts in Spine Fusion. An in Vivo Animal Study, The Journal of Bone and Joint Surgery. 2020; 102(24):p e135.
WEBINARS
Advancements in Bone Grafting in Foot & Ankle Surgery
ASPS: The Use of Advanced Biologics in Foot and Ankle Surgery
NanoBone for Spinal Surgery
NanoBone for Trauma & Sports Medicine
NanoBone for Foot & Ankle Surgery
NanoBone for Orthopedic Oncology
VIDEOS
NanoBone Mechanism of Action
NanoBone QD in a Tibial Defect
NanoBone SBX in a Tibial Defect